SLM (SLM) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
23 Apr, 2026Executive summary
Q1 2026 delivered diluted EPS of $1.54, up from $1.40 year-over-year, and net income attributable to common stock of $304 million, with private education loan originations rising 5% to $2.91 billion.
Market share in private education loans increased to 63% at year-end 2025, up from 52% in 2020.
Strategic execution included robust loan sales, new medical and dental school offerings, and enhanced client acquisition and servicing capabilities.
Positioned for multi-year growth in undergrad and graduate lending due to federal reforms, with originations expected to rise up to 70% over several years.
Focus on innovation, digital infrastructure, and customer-centric strategies to drive growth.
Financial highlights
Net interest income was $375 million, flat year-over-year, with net interest margin improving to 5.29% from 5.27% due to lower funding costs.
Non-interest expenses increased to $171 million from $155 million year-over-year, reflecting targeted investments in graduate lending.
Net charge-offs were $89 million, with net charge-offs as a percentage of average loans in repayment at 2.20%.
Total non-interest income was $185 million, down from $206 million in Q1 2025.
Return on assets was 4.2%, and return on common equity was 56.4%.
Outlook and guidance
Full-year 2026 diluted EPS guidance raised to $3.10–$3.20, assuming full $500 million share repurchase and ~$1 billion incremental loan sales.
Private education loan originations expected to grow 12–14% year-over-year.
Net charge-offs projected at $345–$385 million and non-interest expenses at $750–$780 million for 2026.
Management expects continued focus on loan sales, share repurchases, and maintaining robust liquidity and capital buffers.
Origination growth in 2027 projected to accelerate, especially in graduate lending, with a $5 billion incremental opportunity over time.
Latest events from SLM
- Q1 2025 EPS rose to $1.40 with 7% loan growth and full-year guidance reaffirmed.SLM
Q1 20259 Jul 2026 - Q3 2025 delivered strong profitability, loan growth, and robust capital and liquidity metrics.SLM
Q3 20258 Jul 2026 - PLUS reform and private credit partnerships drive scalable, capital-light, fee-based growth.SLM
Status Update8 Jul 2026 - Strong origination growth, stable credit, and robust loan sale demand support positive outlook.SLM
Barclays 22nd Annual Global Financial Services Conference8 Jul 2026 - All board nominees, compensation, and auditor proposals were approved; no Q&A questions received.SLM
AGM 202622 Jun 2026 - Targeting 70% origination growth by 2028, driven by new products and strategic partnerships.SLM
Morgan Stanley US Financials Conference 202610 Jun 2026 - Virtual meeting to elect directors, approve pay, and ratify auditor set for June 16, 2026.SLM
Proxy filing27 Apr 2026 - Strong 2025 results, strategic growth, and robust governance drive key proxy proposals.SLM
Proxy filing27 Apr 2026 - GAAP EPS rose to $3.46 in 2025, with 6% loan growth and a new $500M buyback program approved.SLM
Q4 202513 Apr 2026